<?xml version="1.0" encoding="UTF-8"?>
<ref id="B129-pharmaceutics-12-00171">
 <label>129.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kim</surname>
    <given-names>S.-S.</given-names>
   </name>
   <name>
    <surname>Peer</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Subramanya</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Asthana</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Habiro</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Y.-G.</given-names>
   </name>
   <name>
    <surname>Manjunath</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Shimaoka</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT Mice</article-title>
  <source>Mol. Ther.</source>
  <year>2010</year>
  <volume>18</volume>
  <fpage>370</fpage>
  <lpage>376</lpage>
  <pub-id pub-id-type="doi">10.1038/mt.2009.271</pub-id>
  <?supplied-pmid 19997090?>
  <pub-id pub-id-type="pmid">19997090</pub-id>
 </element-citation>
</ref>
